← 產業報告目錄
Virtual Biopsy Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders), Type Of Cancer, Type Of Imaging Technology, And End-user, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-30頁數 180報告編號 INSIGHTACE-24a1fcfd3c
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Virtual Biopsy Market on a global scale was estimated at USD 0.8 Billion in 2024 and is projected to attain USD 2.1 Billion by 2034, with a projected CAGR of 12.3% between 2025 and 2034.
The Virtual Biopsy sector involves a non-invasive diagnostic method that offers a safer substitute for conventional tissue biopsy methods by examining tissue properties and identifying anomalies using cutting-edge i. This domain has witnessed substantial transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is driven by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Virtual Biopsy Market Snapshot
Chapter 4. Global Virtual Biopsy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Virtual Biopsy Market Industry Trends
4.10. Global Virtual Biopsy Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Virtual Biopsy Market Segmentation 1: By Type of Target Therapeutic Area, Estimates & Trend Analysis
5.1. Market Share by Type of Target Therapeutic Area, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Target Therapeutic Area:
5.2.1. Oncological Disorders
5.2.2. Neurological Disorders
5.2.3. Cardiovascular Disorders
5.2.4. Ophthalmological Disorders
5.2.5. Endocrine Disorders
5.2.6. Gastrointestinal Disorders
5.2.7. Others
Chapter 6. Virtual Biopsy Market Segmentation 2: By Type of Cancer Targeted, Estimates & Trend Analysis
6.1. Market Share by Type of Cancer Targeted, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Cancer Targeted:
6.2.1. Solid Malignancies
6.2.2. Breast Cancer
6.2.3. Lung Cancer
6.2.4. Prostate Cancer
6.2.5. Colorectal Cancer
6.2.6. Brain Cancer
6.2.7. Others
Chapter 7. Virtual Biopsy Market Segmentation 3: By Type of Imaging Technology, Estimates & Trend Analysis
7.1. Market Share by Type of Imaging Technology, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Imaging Technology:
7.2.1. Magnetic Resonance Imaging
7.2.2. Computed Tomography
7.2.3. X-ray
7.2.4. Ultrasound
7.2.5. Others
Chapter 8. Virtual Biopsy Market Segmentation 4: By End Users, Estimates & Trend Analysis
8.1. Market Share by End Users, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End Users:
8.2.1. Hospitals and Clinics
8.2.2. Research Institutions and Diagnostic Centers
8.2.3. Others
Chapter 9. Virtual Biopsy Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Virtual Biopsy Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.2.3. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.2.4. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.2.5. North America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.3. Europe
9.3.1. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.3.3. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.3.4. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.3.5. Europe Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.4.3. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.4.4. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.4.5. Asia Pacific Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.5. Latin America
9.5.1. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.5.3. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.5.4. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.5.5. Latin America Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Therapeutic Area, 2021-2034
9.6.3. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Cancer Targeted, 2021-2034
9.6.4. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by Type of Imaging Technology, 2021-2034
9.6.5. Middle East & Africa Virtual Biopsy Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. GE Healthcare
10.2.1.1. Business Overview
10.2.1.2. Key Type of Target Therapeutic Area/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Imaging Biometrics
10.2.3. OptoVibronex
10.2.4. ImageBiopsy Lab
10.2.5. Median Technologies
10.2.6. Quibim
10.2.7. Siemens Healthineers
10.2.8. City Imaging and Clinical Labs
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們